IGXBio

IGXBio

Biotechnology company developing advanced dna immunotherapies for hiv infection.

Launch date
Employees
Market cap
-
Enterprise valuation
CAD3—4m (Dealroom.co estimates Dec 2010.)
Lenexa Kansas (HQ)
  • Edit
DateInvestorsAmountRound

$470k

Seed
Total FundingCAD641k

Recent News about IGXBio

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.